Neural Regeneration Research ›› 2024, Vol. 19 ›› Issue (6): 1185-1186.doi: 10.4103/1673-5374.385871

Previous Articles     Next Articles

Smart electrochemical sensing of amyloid-beta to manage total Alzheimer’s diseases

Ajeet Kaushik   

  1. NanoBioTech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, Lakeland, FL, USA
    School of Engineering, University of Petroleum and Energy Studies (UPES), Dehradun, India
  • Online:2024-06-15 Published:2023-11-17
  • Contact: Ajeet Kaushik, PhD, akaushik@floridapoly.edu.
  • Supported by:
    Ajeet Kaushik acknowledges Florida Polytechnic University, Lakeland, USA for providing support and facilities.

Abstract: Need for Alzheimer’s disease progression monitoring: Alzheimer’s disease (AD) is an irreversible progressive brain disorder that causes severe and incurable neuro-impairment. The World Health Organization estimates that 55 million people are affected by AD dementia by 2020 which may exceed 78 million by 2030 and 139 in 2050. The estimated cost to manage AD is above US$ 1.3 trillion, which will further increase to US$ 2.8 trillion by 2030. According to Alzheimer’s Diseases International and Bright Focus Foundation, the world gets a new AD patient every 3 seconds, 60% of the dementia population belongs to low and middle-income countries, and this will increase to 71% by 2050.